IntelGenx Reports First Quarter 2019 Financial Results
May 09, 2019 16:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 09, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the first quarter...
IntelGenx Announces the Appointment of André Godin as President and Chief Financial Officer
May 08, 2019 16:15 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that its Board of...
IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil
May 08, 2019 07:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has entered into a...
IntelGenx to Report First Quarter 2019 Financial Results on May 9, 2019 – Conference Call to Follow
May 02, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its first quarter 2019 financial results...
IntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film Technology
May 01, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent...
IntelGenx to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
April 25, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 25, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that its Executive...
IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit
April 08, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its...
IntelGenx Presents at 14th International Conference on Alzheimer’s and Parkinson’s Disease
April 04, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 04, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced its two Montelukast poster...
IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA
April 02, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced it has received a Complete...
GREATER CANNABIS TO BEGIN CLINICAL STUDY OF CBD ABSORPTION THROUGH ITS MULTIFUNCTIONAL, MULTILAYER INTRA-ORAL DRUG DELIVERY TECHNOLOGY
April 01, 2019 10:25 ET
|
The Greater Cannabis Company, Inc.
Study Continues To Expand, Drive Commercialization Of Company’s Eluting Patch Technology To LPs, Consumer Product And Pharmaceutical Companies BALTIMORE, MD, April 01, 2019 (GLOBE NEWSWIRE)...